Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Reprezentatywne Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

Here, we describe an in vitro model for isolating and differentiating murine airway epithelial cells, focusing on their acclimation to chronic cigarette smoke extract (CSE). The model could be utilized to comprehensively characterize the multi-omics impact of CSE, which possibly provides insights into the cellular responses under chronic smoke exposure.

Streszczenie

Chronic obstructive pulmonary disease (COPD) is largely attributed to tobacco smoke exposure. Investigating how airway epithelial cells functionally adapt to tobacco smoke is crucial for understanding the pathogenesis of COPD. The present study was to set up an in vitro model using primary murine airway epithelial cells to mimic the real-life impact of tobacco smoke. Unlike established cell lines, primary cells retain more in vivo-like properties, including growth patterns, aging, and differentiation. These cells exhibit a sensitive inflammatory response and efficient differentiation, thus closely representing physiological conditions. In this model, primary murine airway epithelial cells were cultured for 28 days under an air-liquid interface with an optimal concentration of cigarette smoke extract (CSE), which led to the transformation of a monolayer of undifferentiated cells into a pseudostratified columnar epithelium, indicative of CSE acclimation. Comprehensive multi-omics analyses were then applied to elucidate the mechanisms by which CSE influences the differentiation of basal airway cells. These insights provide a deeper understanding of the cellular processes underpinning COPD progression in response to tobacco smoke exposure.

Wprowadzenie

Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition with complex characteristics, while patients with COPD gradually tend to be younger1. Smoking, a primary risk factor for COPD2, has a profound impact on airway epithelial cells, which serve as the initial barrier against tobacco smoke. Despite this known association, the detailed mechanisms through which tobacco smoke induces changes in airway epithelial cells remain inadequately explored. A thorough understanding of these molecular alterations is essential for identifying early diagnostic markers and therapeutic targets for COPD.

Protokół

The overall protocol requires 44 days, including 1 day for preparation of airway epithelial cells isolated from murine tracheas, 15 days for cell proliferation, and 28 days for CSE stimulation at the air-liquid interface. All experimental animals are housed in the SPF Barrier Animal Room of the Animal Experiment Center of Capital Medical University and have been reviewed and approved by the Animal Experiment and Laboratory Animal Ethics Committee of Capital Medical University (AEEI-2020-100) to meet the requirements of ARRIVE guidelines7.

1. Isolation of primary murine airway epithelial cells from murine trache....

Reprezentatywne Wyniki

Differentiation
Murine airway epithelial cells successfully differentiated after culturing at an air-liquid interface with a differentiation medium for 28 days. The presence of ciliated and goblet cells was demonstrated by immunofluorescence assay of cilia marker acetylated α-Tubulin (green; Figure 3A) and the goblet cell marker Mucin5AC, respectively6 (red; Figure 3B).

Determination of CSE concentr.......

Dyskusje

COPD is a common chronic airway inflammatory disease. Exposure to tobacco smoke leads to chronic airway inflammation, airway remodeling, and lung structural destruction, which is the result of the interaction of various structural cells and immune cells10. As the front line of the innate immune system in the lung, airway epithelial cells play a very important role during the development of the disease11. In this point of view, clarifying how epithelial cells change and regu.......

Ujawnienia

The authors have nothing to disclose.

Podziękowania

This study was supported by the National Natural Science Foundation of China (82090013).

....

Materiały

NameCompanyCatalog NumberComments
100x Penicillin/Streptomycin solutionGibco15140122
24 mm Transwell with 0.4 µm Pore Polyester Membrane Insert, SterileBIOFILTCS016012
40 µm Cell StrainerFalcon352340
500x Gentamicin/Amphotericin SolutionGibcoR01510
acetylated α-TubulinCST#5335
Acetyl-α-Tubulin (Lys40) (D20G3)XP Rabbit mAb cellsignal#5335
Animal Component Free Cell Dissociation KitStemcell05426
Anti-pan Cytokeratin antibodyabcamab7753
CigaretteMarlboro
Claudin3immunowayYT0949
Deoxyribonuclase I from bovine pancreasSigma-AldrichDN25
Deoxyribonuclase I from bovine pancreasSigmaDN25
Ham’s F-12Sigma-AldrichN6658
Heparin Solution Stemcell07980
Hydrocortisone Stock SolutionStemcell07925
Mucin 5ACabcamab212636
Occludinproteintech27260-1-AP
PBSCytosciCBS004S-BR500
Penicillin-Streptomycin SolutionGibco15140122
PneumaCult-ALI
Basal Medium
Stemcell05002 
PneumaCult-ALI 10x SupplementStemcell05003 
PneumaCult-ALI Maintenance SupplementStemcell05006
PneumaCult-Ex Plus 50x SupplementStemcell05042
PneumaCult-Ex Plus Basal MediumStemcell05041
Pronase ESigma-AldrichP5147
Rat tail collagenCorning354236
Trypan BlueStemcell07050 

Odniesienia

  1. Ritchie, A. I., Martinez, F. J. The challenges of defining early chronic obstructive pulmonary disease in the general population. Am J Respir Crit Care Med. 203 (10), 1209-1210 (2021).
  2. Caramori, G., Kirkham, P., Barczyk, A., Di Stefano, A., Adcock, I.

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

BiologyAirway Epithelial CellsTobacco SmokeChronic Obstructive Pulmonary DiseaseCOPDCigarette Smoke ExtractPrimary Murine CellsDifferentiationInflammatory ResponseAir liquid InterfacePseudostratified Columnar EpitheliumCellular Processes

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone